Hepregen Corporation Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Hepregen Corporation is a biotechnology research company based in Medford, Massachusetts. It focuses on advancing and commercializing its liver-on-a-chip platform, HepatoPac, to improve safety assessment and drug development workflows for pharmaceutical and biotechnology companies. The HepatoPac system assembles human hepatocytes into structured colonies surrounded by supportive cells, aiming to replicate key liver functions and metabolism in vitro for up to four weeks, with potential applications in toxicity screening, drug discovery, biomarker identification, and disease modeling. The company serves its customers—primarily drug developers and researchers—by offering a platform that integrates into existing work-flows and supports high-content screening, DMPK, and safety evaluation in preclinical analysis. Hepregen originated as a spin-out from MIT and has established collaborations with numerous pharmaceutical partners, reflecting its position within the evolving area of in vitro liver models for preclinical research.

Sign up for free to view info

Company overview Employee directory